Tomokazu Ohishi

TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling.

Takafumi Ishida, Taiki Tojo, Taku Aoki et al. · Proceedings of the National Academy of Sciences · 1996 · 345 citations · Full text

Inflammation, Transcriptional Regulation, Protein Function +15

Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics

Hiroyuki Seimiya, Yukiko Muramatsu, Tomokazu Ohishi et al. · Cancer Cell · 2005 · 165 citations · Full text

Tankyrase 1, Oncogenic Agent, Medicine +8

Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane

Tomokazu Ohishi, Yosuke Kishimoto, Norimasa Miura et al. · Cancer Letters · 2002 · 92 citations

Colon Carcinogenesis, Chemoprevention Strategy, Gastrointestinal Pharmacology +6

Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer

Nuala McCabe, Maria Antonietta Cerone, Tomokazu Ohishi et al. · Oncogene · 2009 · 66 citations

Oncology, Tankyrase 1, Medicine +10

SF-1 deficiency causes lipid accumulation in Leydig cells via suppression of STAR and CYP11A1

Megumi Hatano, Toshiro Migita, Tomokazu Ohishi et al. · Endocrine · 2016 · 50 citations

Oxysterol, Lipid Accumulation, Lipid Peroxidation +9